Growth Metrics

Integra Lifesciences Holdings (IART) Research & Development (2009 - 2026)

Integra Lifesciences Holdings recorded quarterly Research & Development of $23.5 million in Q1 2026, down 5.2% quarter-over-quarter from $24.8 million in Q4 2025, and down 4.96% year-over-year from $24.7 million in Q1 2025.

Integra Lifesciences Holdings' Research & Development history runs 18 years deep, the most recent figure standing at $23.5 million for Q1 2026.

  • In Q1 2026, Research & Development fell 4.96% year-over-year to $23.5 million; the TTM figure through Mar 2026 stood at $97.7 million (down 13.61% YoY), while the FY2025 annual figure was $99.0 million, down 14.22% from the prior year.
  • Research & Development came in at $23.5 million for Q1 2026 at Integra Lifesciences Holdings, down from $24.8 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $31.2 million in Q4 2024 to a low of $22.5 million in Q3 2025.
  • A 5-year average of $26.1 million and a median of $26.6 million in 2023 frame the typical range for Research & Development.
  • Across the five-year window, Research & Development grew 28.52% in 2024 and decreased 20.57% in 2025, its largest moves.
  • Integra Lifesciences Holdings' Research & Development stood at $26.8 million in 2022, then fell by 9.33% to $24.3 million in 2023, then gained by 28.52% to $31.2 million in 2024, then slipped by 20.57% to $24.8 million in 2025, then declined by 5.2% to $23.5 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods registered $23.5 million, $24.8 million, and $22.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 767.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 413.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 722.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 516.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 263.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -461.27 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 145.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 345.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.80 Mn
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn 23.50 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 23.50 Mn
Dec 31, 2025 24.79 Mn
Sep 30, 2025 22.46 Mn
Jun 30, 2025 27.00 Mn
Mar 31, 2025 24.73 Mn
Dec 31, 2024 31.21 Mn
Sep 30, 2024 27.44 Mn
Jun 30, 2024 29.77 Mn
Mar 31, 2024 26.97 Mn
Dec 31, 2023 24.28 Mn
Sep 30, 2023 26.60 Mn
Jun 30, 2023 26.59 Mn
Mar 31, 2023 26.72 Mn
Dec 31, 2022 26.78 Mn
Sep 30, 2022 24.74 Mn
Jun 30, 2022 25.59 Mn
Mar 31, 2022 24.09 Mn
Dec 31, 2021 24.73 Mn
Sep 30, 2021 25.83 Mn
Jun 30, 2021 20.12 Mn
Mar 31, 2021 22.37 Mn
Dec 31, 2020 22.18 Mn
Sep 30, 2020 19.46 Mn
Jun 30, 2020 14.93 Mn
Mar 31, 2020 20.82 Mn
Dec 31, 2019 24.62 Mn
Sep 30, 2019 19.00 Mn
Jun 30, 2019 17.63 Mn
Mar 31, 2019 1.70 Mn
Dec 31, 2018 20.30 Mn
Sep 30, 2018 20.31 Mn
Jun 30, 2018 19.11 Mn
Mar 31, 2018 18.33 Mn
Dec 31, 2017 17.18 Mn
Sep 30, 2017 15.03 Mn
Jun 30, 2017 15.75 Mn
Mar 31, 2017 15.49 Mn
Dec 31, 2016 13.90 Mn
Sep 30, 2016 15.12 Mn
Jun 30, 2016 14.68 Mn
Mar 31, 2016 14.45 Mn
Dec 31, 2015 13.87 Mn
Sep 30, 2015 13.94 Mn
Jun 30, 2015 12.01 Mn
Mar 31, 2015 11.08 Mn
Dec 31, 2014 10.01 Mn
Sep 30, 2014 11.13 Mn
Jun 30, 2014 13.75 Mn
Mar 31, 2014 12.57 Mn
Dec 31, 2013 5.05 Mn
Sep 30, 2013 13.05 Mn
Jun 30, 2013 11.81 Mn
Mar 31, 2013 12.72 Mn
Dec 31, 2012 12.86 Mn
Sep 30, 2012 13.11 Mn
Jun 30, 2012 13.13 Mn
Mar 31, 2012 11.91 Mn
Dec 31, 2011 13.40 Mn
Sep 30, 2011 13.19 Mn
Jun 30, 2011 12.71 Mn
Mar 31, 2011 12.15 Mn
Dec 31, 2010 13.33 Mn
Sep 30, 2010 11.72 Mn
Jun 30, 2010 11.76 Mn
Mar 31, 2010 11.30 Mn
Dec 31, 2009 11.81 Mn
Sep 30, 2009 11.53 Mn
Jun 30, 2009 10.30 Mn